Our Chief Executive has today written to the Company Chemists Association, National Pharmacy Association and the Association of Independent Multiple Pharmacies. The letter follows our previous joint statement with the PSNI on our regulatory approach in challenging circumstances, including the current COVID-19 pandemic.
The General Pharmaceutical Council (GPhC) has today given temporary registration to 3332 pharmacists and 2909 pharmacy technicians who had left the register. This enables them to return to work during the current COVID-19 (coronavirus) pandemic.
“Yesterday (25 March) we brought together representatives from student and trainee representative bodies, universities, employers, education and training bodies and others from across the UK to discuss the key issues in relation to pre-registration training during the COVID-19 pandemic.
Duncan Rudkin, Chief Executive of the GPhC, said:
“We know that pre-registration trainees are working extremely hard in very challenging circumstances to help the pharmacy team and patients and the public. We would like to thank everyone for their significant contribution.
Duncan Rudkin, Chief Executive of the General Pharmaceutical Council, said:
“Pharmacies and pharmacy professionals are working on the frontline, under significant pressure, to support the public and patients during the Covid-19 pandemic.
Due to the challenges and pressures on the pharmacy sector at this time, and the increasing number of cases of COVID-19, we have decided to postpone the revalidation submission date for those registrants who are due to submit between 20 March and 31 August 2020 (inclusive).
For updates related to the coronavirus pandemic, including GPhC statements and questions and answers, please see our dedicated COVID-19 information page.
Today the NHS has called upon former pharmacy professionals, alongside doctors, nurses and other health professionals, to re-register and help in tackling the greatest global health threat in the history of the health service. The plans are part of the extensive work to date to prepare for the likely health effects of the Covid-19 pandemic.
General Pharmaceutical Council Chief Executive, Duncan Rudkin has issued the following statement in response to reports of some instances of raised prices and locum rates during the COVID-19 pandemic
